About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Survival in Metastatic Melanoma has Changed: Where are we Now and Immunotherapy Treatment
By
Cleveland Clinic Taussig Cancer Institute
FEATURING
Pauline Funchain
By
Cleveland Clinic Taussig Cancer Institute
FEATURING
Pauline Funchain
115 views
December 11, 2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
10:01
AAD 2024 Insights
AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma
Feat.
V. Sondak
12:46
Stanford Medicine
FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …
Feat.
A. Betof Warner
24:14
Masterclasses in Dermatology
Advances in the Treatment of Melanoma
Feat.
D. Fisher
18:21
Vanderbilt University Medical Center (VUMC)
NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…
Feat.
D. Johnson
25:44
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Melanoma in the Molecular Age - Part 1: New Tools for Diagnosis, Pro…
Feat.
G. Hosler
05:37
Melanoma Bridge 2023
COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…
Feat.
R. Dummer
20:55
2023 West Oncology Conference
2023 West Oncology Conference: Melanoma Updates
Feat.
M. Mooradian
04:45
Sapna Patel
Optimal Duration of Neoadjuvant Treatment in Melanoma: What We Do No…
20:32
Melanoma Bridge 2023
Targeted Therapy in BRAF-Mutated Metastatic Melanoma
Feat.
R. Dummer
13:31
Melanoma Bridge 2023
What Is the Best Initial Treatment for Unresectable Mucosal Melanoma…
Feat.
J. Luke
17:32
Insights from 2023 Society for Melanoma Research Annual Meeting
2023 SMR Congress Insights: "DREAMseq Trial Final 2-year OS Dat…
Feat.
M. Atkins
16:14
Kim Margolin
Highlights From the Recent Melanoma Research Alliance Meeting: What&…
24:22
Total Health
2022 Sedona Melanoma Updates From ASCO: Overview and Treatment
Feat.
K. Lewis
13:20
Penn Medicine Abramson Cancer Center
Penn Medicine Updates in Oncology 2023: Melanoma
Feat.
J. Cohen
10:39
Moffitt Cancer Center
Clinical Implications of COMBI-d and COMBI-v Trials on OS in Patient…
Feat.
A. Tarhini
27:29
Total Health
2023 ASCO® Direct Philadelphia: Melanoma Updates
Feat.
M. Orloff
21:38
Penn Medicine Abramson Cancer Center
Updates in Systemic Therapy for Melanoma
Feat.
T. Mitchell
17:07
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Melanoma Brain Metastases: Successes, Failures, and Future Opportuni…
Feat.
M. Postow
13:55
Northwestern Medicine Oncology and Hematology
Utilization of COMBI-APlus Data in Clinical Practice: Adapted Pyrexi…
Feat.
S. Chandra
07:53
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "aTezolizumab, bevAcizumab, and Cobimetinib…
Feat.
E. Burton
